Abstract
Abstract
Background
Systemic infection has always been considered a relative contraindication to neuraxial anesthesia, despite the fact that infectious complications are relatively uncommon. Pregnancy-related physiological changes and coronavirus disease (COVID-19) neurotropic features may facilitate the virus’ entry into the central nervous system. The principal aim of this study was to test the safety of spinal anesthesia in “severe acute respiratory syndrome coronavirus 2” (SARS-CoV-2)-positive pregnant women and to examine cerebrospinal fluid (CSF) characteristics.
Methods
We conducted a prospective observational single-center study in asymptomatic or paucisymptomatic consecutive pregnant SARS-CoV-2 patients who underwent spinal anesthesia for cesarean section. Women with severe infection were excluded because they underwent general anesthesia. At the time of spinal anesthesia, we collected CSF samples, and then we performed a chemical-physical analysis to look for signs of inflammation and for SARS-CoV-2 genome.
Results
We included 26 women. No spinal anesthesia complications were reported in the perioperative period and after 2 months. All CSF samples were crystal clear, and all physical-chemical values were within physiological ranges: the median concentration of CSF/plasma glucose ratio was 0.66, IQR 0.5500 (0.6000–0.7100), and the average CSF protein concentration value was 23.2 mg/dl (SD 4.87). In all samples, genomes of SARS-CoV-2 and other neurotropic viruses were not detected.
Conclusions
Spinal anesthesia was safe in SARS-CoV-2 pregnant women with mild disease; no clinical maternal complications were detected, and no CSF changes indicative of inflammatory or infectious diseases that would compromise the safety of the procedure were found.
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Rasmussen SA, Jamieson DJ (2022) COVID-19 and pregnancy. Infect Dis Clin North Am 36:423–433
2. Bressan F, Caramelli F, De Robertis E, Di Giacinto I, Frigo MG, Micaglio M, Astuto M, Petrini F (2020) Indicazioni per la gestione anestesiologico-rianimatoria di pazienti con sospetta o accertata infezione da SARS-CoV-2 (Covid-19) nel peripartum. Guidelines SIAARTI
3. Bampoe S, Odor PM, Lucas DN (2020) Novel coronavirus SARS-CoV-2 and COVID-19. Practice recommendations for obstetric anaesthesia: what we have learned thus far. Int J Obstet Anesth 43:1–8
4. Gritsenko K, Marcello D, Liguori GA, Jules-Elysee K, Memtsoudis SG (2012) Meningitis or epidural abscesses after neuraxial block for removal of infected hip or knee prostheses. Br J Anaesth 108:485–490
5. Horlocker TT, Wedel DJ (2006) Regional anesthesia in the immunocompromised patient. Reg Anesth Pain Med 31:334–345